Revolo Biotherapeutics Announces US FDA Approval of IND Application for Phase 2 Trial of ‘1104 in Eosinophilic Esophagitis

NEXT STORY
Medicenna Announces Submission of Clinical Trial Application in Australia for a Phase 1/2 Study of MDNA11
PREV STORY
$74 Billion Pain Management Drugs Global Market to 2026 – by Drug Class, Indication, Distribution Channel and Region
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chi-Med Initiates a Phase I Trial of IDH1/2 Dual Inhibitor in Patients with Hematological Malignancies in China

author_avatar
NASDAQ Market News

AzurRx BioPharma Announces Positive Interim Data in Phase 2 Clinical Trial of MS1819 in Combination with PERT in the Treatment of Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

author_avatar
NASDAQ Market News

Pesquisadores, sobreviventes, apoiadores e médicos reúnem-se para discutir inovações em pesquisa, tratamento e apoio à luta contra o câncer de pulmão na maior conferência mundial sobre a doença

TORONTO, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Pacientes, sobreviventes e apoiadores unem-se a pesquisadores ...

author_avatar
NASDAQ Market News